Molecular recognition and regulation in microRNA processing by the DGCR8 protein

DGCR8 蛋白对 microRNA 加工的分子识别和调控

基本信息

  • 批准号:
    7826938
  • 负责人:
  • 金额:
    $ 26.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-10 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) have been recognized as an important class of non-coding RNAs that are involved in a variety of biological and pathological processes. The broad, long-term objectives are to elucidate the molecular mechanism through which long miRNA primary transcripts (pri-miRNAs) are specifically recognized by cellular factors for processing and how their maturation is regulated through a mechanism involving heme. Specifically, we will focus on the structure and function of a key factor-an human RNA binding protein called DGCR8 that is heterozygously deleted in DiGeorge syndrome patients. We expect to fill major gaps in our current knowledge of miRNAs: some critical features of miRNA genes have not been identified so that miRNA genes cannot be accurately predicted from genomic sequences; and little is known about how the processing of miRNAs are regulated. Specific aim 1 will elucidate how DGCR8 interacts with pri-miRNAs. The protein-RNA interface will be examined using biochemical and X-ray crystallographic methods. The origin of the binding cooperativity will be investigated using mutagenesis methods. In specific aim 2, the interactions between DGCR8 and the heme cofactor will be revealed. The amino acid residues important for heme binding will be identified using site-directed mutagenesis and screening methods. The structure of the heme-binding domain will be determined using X-ray crystallography or NMR. The molecular mechanism of autoinhibition of DGCR8 will be examined using in vitro methods. In specific aim 3, the importance of the heme-DGCR8 interaction and the autoinhibition of DGCR8 in pri-miRNA processing will be investigated in human cell cultures. Medical revelence: MicroRNAs are a new class of genes that are involved in important biological and disease processes. Our research aims to improve our abilities to find these genes in the human genome, to develop better theraprutic microRNAs that can modulate abnormal gene expression in disease states. Our discovery that heme may be involved in regulating the processing of microRNAs suggest that they can be used as therapeutic agents for microRNA-related diseases.
描述(由申请人提供):MicroRNAs (miRNAs)已被认为是一类重要的非编码rna,参与多种生物和病理过程。广泛而长期的目标是阐明长miRNA初级转录物(pri-miRNA)被细胞因子特异性识别并加工的分子机制,以及它们的成熟如何通过涉及血红素的机制进行调节。具体来说,我们将关注一个关键因子的结构和功能——一种被称为DGCR8的人类RNA结合蛋白,它在DiGeorge综合征患者中被杂合删除。我们希望填补我们目前对miRNA知识的主要空白:miRNA基因的一些关键特征尚未被鉴定,因此无法从基因组序列中准确预测miRNA基因;而对于mirna的加工是如何被调控的,我们知之甚少。特异性目的1将阐明DGCR8如何与pri- mirna相互作用。蛋白质- rna界面将使用生化和x射线晶体学方法进行检查。结合协同性的起源将利用诱变方法进行研究。在具体目标2中,DGCR8和血红素辅助因子之间的相互作用将被揭示。对血红素结合重要的氨基酸残基将使用定点诱变和筛选方法进行鉴定。血红素结合区域的结构将使用x射线晶体学或核磁共振来确定。DGCR8自身抑制的分子机制将采用体外方法进行研究。在特定目标3中,将在人类细胞培养中研究血红素-DGCR8相互作用和DGCR8在pri-miRNA加工中的自我抑制的重要性。医学意义:MicroRNAs是一类新的基因,参与重要的生物和疾病过程。我们的研究旨在提高我们在人类基因组中发现这些基因的能力,以开发更好的治疗性microrna,可以调节疾病状态下异常基因的表达。我们发现血红素可能参与调节microrna的加工过程,这表明它们可以用作microrna相关疾病的治疗剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Feng Guo其他文献

Feng Guo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Feng Guo', 18)}}的其他基金

An automated portable system for detecting and treating opioid induced respiratory depression
用于检测和治疗阿片类药物引起的呼吸抑制的自动化便携式系统
  • 批准号:
    10592367
  • 财政年份:
    2022
  • 资助金额:
    $ 26.07万
  • 项目类别:
An automated portable system for detecting and treating opioid induced respiratory depression
用于检测和治疗阿片类药物引起的呼吸抑制的自动化便携式系统
  • 批准号:
    10478481
  • 财政年份:
    2022
  • 资助金额:
    $ 26.07万
  • 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
  • 批准号:
    10645137
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
  • 批准号:
    10453620
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
开发针对COVID-19的三维反义寡核苷酸药物
  • 批准号:
    10280762
  • 财政年份:
    2021
  • 资助金额:
    $ 26.07万
  • 项目类别:
An acoustofluidic avidity cytometer for massive parallel profiling single autoreactive T cell in autoimmune disease
用于大规模平行分析自身免疫性疾病中单个自身反应性 T 细胞的声流控亲和细胞仪
  • 批准号:
    10002377
  • 财政年份:
    2020
  • 资助金额:
    $ 26.07万
  • 项目类别:
Acoustic assembly of patient tumor organoids for modeling cancer immunity
用于模拟癌症免疫的患者肿瘤类器官的声学组装
  • 批准号:
    10187568
  • 财政年份:
    2020
  • 资助金额:
    $ 26.07万
  • 项目类别:
Acoustic assembly of patient tumor organoids for modeling cancer immunity
用于模拟癌症免疫的患者肿瘤类器官的声学组装
  • 批准号:
    10041819
  • 财政年份:
    2020
  • 资助金额:
    $ 26.07万
  • 项目类别:
STRUCTURE OF THE DIMERIZATION DOMAIN OF DIGEORGE CRITICAL REGION 8
DIGEORGE关键区8的二聚化结构域的结构
  • 批准号:
    8361692
  • 财政年份:
    2011
  • 资助金额:
    $ 26.07万
  • 项目类别:
Molecular recognition and regulation in microRNA processing by the DGCR8 protein
DGCR8 蛋白对 microRNA 加工的分子识别和调控
  • 批准号:
    7628447
  • 财政年份:
    2007
  • 资助金额:
    $ 26.07万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 26.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了